JPWO2021099531A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021099531A5 JPWO2021099531A5 JP2022529813A JP2022529813A JPWO2021099531A5 JP WO2021099531 A5 JPWO2021099531 A5 JP WO2021099531A5 JP 2022529813 A JP2022529813 A JP 2022529813A JP 2022529813 A JP2022529813 A JP 2022529813A JP WO2021099531 A5 JPWO2021099531 A5 JP WO2021099531A5
- Authority
- JP
- Japan
- Prior art keywords
- orally disintegrating
- months
- disintegration
- tablet according
- zonisamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19383034.6 | 2019-11-22 | ||
EP19383034 | 2019-11-22 | ||
PCT/EP2020/082809 WO2021099531A1 (fr) | 2019-11-22 | 2020-11-20 | Comprimés orodispersibles de zonisamide |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023502738A JP2023502738A (ja) | 2023-01-25 |
JPWO2021099531A5 true JPWO2021099531A5 (fr) | 2023-11-08 |
Family
ID=68808236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022529813A Pending JP2023502738A (ja) | 2019-11-22 | 2020-11-20 | ゾニサミド口腔分散性錠剤 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP4061328B1 (fr) |
JP (1) | JP2023502738A (fr) |
ES (1) | ES2976470T3 (fr) |
PT (1) | PT4061328T (fr) |
WO (1) | WO2021099531A1 (fr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2393640T3 (es) * | 2008-02-13 | 2012-12-26 | Dainippon Sumitomo Pharma Co., Ltd. | Comprimidos bucodisgregables |
US10292934B2 (en) | 2012-09-20 | 2019-05-21 | Daicel Corporation | Disintegrating particle composition containing acid-type carboxymethylcellulose and crystalline cellulose, and orally disintegrating tablet containing said composition |
-
2020
- 2020-11-20 WO PCT/EP2020/082809 patent/WO2021099531A1/fr unknown
- 2020-11-20 JP JP2022529813A patent/JP2023502738A/ja active Pending
- 2020-11-20 ES ES20808117T patent/ES2976470T3/es active Active
- 2020-11-20 PT PT208081174T patent/PT4061328T/pt unknown
- 2020-11-20 EP EP20808117.4A patent/EP4061328B1/fr active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6162196B2 (ja) | 遅延性持続ドラッグデリバリー | |
JP6162197B2 (ja) | 即時/遅延ドラッグデリバリー | |
JP2015091822A5 (fr) | ||
JP2011500583A5 (fr) | ||
TWI491395B (zh) | 一種內含用以治療神經退化性疾病之立即釋出與長效釋出藥物的口服劑量配方 | |
JPH05213741A (ja) | デプレニル/l−ドーパ/カルビドーパ含有の医薬組成物 | |
JP2018118966A5 (fr) | ||
CA3157788A1 (fr) | Composition pharmaceutique orale comprenant un compose carbamate et procede de preparation de cette composition | |
JP2019019113A (ja) | メマンチン塩酸塩含有口腔内崩壊錠 | |
EP3813822A2 (fr) | Compositions pharmaceutiques solides d'administration par voie orale comprenant du tériflunomide | |
JP6366794B2 (ja) | 原薬の化学的安定性や服用感を向上した、口腔内崩壊錠 | |
WO2013109225A1 (fr) | Formulations pharmaceutiques en comprimés comprenant du ceftibutène | |
JPWO2021099531A5 (fr) | ||
WO2012080703A1 (fr) | Composition pharmaceutique comprenant de l'imatinib | |
JP2019052147A (ja) | 化学的な安定性が改善された、プレガバリン含有口腔内崩壊錠 | |
JP2022046737A (ja) | 安定性及び溶出率が改善されたタダラフィル含有及びタムスロシン含有のカプセル複合製剤 | |
JP2018118909A (ja) | プレガバリン含有医薬組成物 | |
KR20130023127A (ko) | 프레가발린을 포함하는 서방성 제제 | |
JP2019182859A (ja) | 口腔内崩壊錠 | |
JP2018172361A (ja) | 光安定性を改善した、デュロキセチンを含有する固形製剤 | |
JP7423297B2 (ja) | 口腔内崩壊錠およびその製造方法 | |
JP6858873B2 (ja) | セレコキシブを含む錠剤 | |
JP6336651B1 (ja) | 化学的安定性が改善されたエソメプラゾール塩を含有する錠剤 | |
JP2016138073A (ja) | 安定性を改善した、シロドシンを含有する錠剤 | |
WO2013180675A1 (fr) | Formulation en comprimés comprenant de la dapoxétine |